Demo Data from EDBT 2026 / reviewers in the wild / expert
Tianyun He
dblp:342/2985
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2025
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › computational microbiology › microbiome analysis
differential abundance testing |
0.9 | 1 | 2025 | reDA: differential abundance testing on scATAC-seq data using random walk with restart · Bioinform. 2025 |
Bioinformatics and computational biology › single-cell analysis › single-cell epigenomics
single-cell ATAC-seq analysis |
0.9 | 1 | 2025 | reDA: differential abundance testing on scATAC-seq data using random walk with restart · Bioinform. 2025 |
Methods — techniques the papers use, named apart from their topics
random walk with restart · 0.9
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | reDA: differential abundance testing on scATAC-seq data using random walk with restartabstractSUMMARY: Identifying cell states associated with disease progression or experimental perturbations from single-cell Assay for Transposase Accessible Chromatin using sequencing (scATAC-seq) data is critical for unraveling disease pathogenesis. However, the high dimensionality, extreme sparsity, and nearly binary nature of scATAC-seq data pose significant challenges. Here, we present reDA, a cluster-free computational framework that performs differential abundance testing based on the random walk with restart. Through comprehensive experiments on simulated and real datasets, reDA outperforms six baseline methods, demonstrating superior accuracy, computational efficiency, and the ability to capture disease-specific molecular signatures. AVAILABILITY AND IMPLEMENTATION: The reDA along with detailed documentation is freely available at https://github.com/Jinsl-lab/reDA. It can be seamlessly integrated into existing scATAC-seq analysis workflows. Jiao Hua, Lu Ba, Tianyun He, Boran Yang, Shuilin Jin |
Bioinform. | 4 |